AusPAR: Certolizumab pegol (rbe)

Australian Public Assessment Report

AusPAR

AusPAR: Certolizumab pegol (rbe) [PDF, 332.99 KB]

AusPAR: Certolizumab pegol (rbe) [Word, 349.2 KB]

Attachment: Product Information for Certolizumab pegol (rbe) [PDF, 648.21 KB]

Attachment: Product Information for Certolizumab pegol (rbe) [Word, 175.91 KB]

Device/Product Name

Cimzia

Active ingredients

Certolizumab pegol (rbe)

AusPAR Date

13 February 2020

Published

18 February 2020

Submission Number

PM-2018-04256-1-3

Submission Type

Extension of indications

Decision

Approved